These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 17156408)
1. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate. Elmaagacli AH; Koldehoff M; Zakrzewski JL; Steckel NK; Ottinger H; Beelen DW Br J Haematol; 2007 Jan; 136(2):212-9. PubMed ID: 17156408 [TBL] [Abstract][Full Text] [Related]
2. Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells. Koldehoff M; Zakrzewski JL; Beelen DW; Elmaagacli AH Cancer Gene Ther; 2013 Jul; 20(7):421-7. PubMed ID: 23788109 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of EDAG expression by retrovirus-mediated small interfering RNA inhibits the growth and IL-8 production of leukemia cells. Ling B; Zhou Y; Feng D; Shen G; Gao T; Shi Y; Wei H; Tian Z Oncol Rep; 2007 Sep; 18(3):659-64. PubMed ID: 17671716 [TBL] [Abstract][Full Text] [Related]
4. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349 [TBL] [Abstract][Full Text] [Related]
5. Human promoter mutations unveil Oct-1 and GATA-1 opposite action on Gfi1b regulation. Hernández A; Villegas A; Anguita E Ann Hematol; 2010 Aug; 89(8):759-65. PubMed ID: 20143233 [TBL] [Abstract][Full Text] [Related]
6. PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis. Spinello I; Quaranta MT; Pasquini L; Pelosi E; Petrucci E; Pagliuca A; Castelli G; Mariani G; Diverio D; Foà R; Testa U; Labbaye C Oncogene; 2009 Jun; 28(23):2276-88. PubMed ID: 19421145 [TBL] [Abstract][Full Text] [Related]
7. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line. Casagrande G; te Kronnie G; Basso G Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578 [TBL] [Abstract][Full Text] [Related]
8. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia. Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204 [TBL] [Abstract][Full Text] [Related]
9. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA. Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680 [TBL] [Abstract][Full Text] [Related]
11. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia. Ge Y; Stout ML; Tatman DA; Jensen TL; Buck S; Thomas RL; Ravindranath Y; Matherly LH; Taub JW J Natl Cancer Inst; 2005 Feb; 97(3):226-31. PubMed ID: 15687366 [TBL] [Abstract][Full Text] [Related]
12. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin]. Gao H; Shi J; Ge SF; DI W Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933 [TBL] [Abstract][Full Text] [Related]
13. PU.1 silencing leads to terminal differentiation of erythroleukemia cells. Atar O; Levi BZ Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566 [TBL] [Abstract][Full Text] [Related]
14. [Expression of transcription factor LYL1 in leukemia and its possible role in leukemogenesis]. Meng YS; Zhang YX; Ai GW; Meng XQ; Liu W; Wei R; Jiang W Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):749-52. PubMed ID: 19176012 [TBL] [Abstract][Full Text] [Related]
15. JNK2 and p38 MAPK over-expressions do not represent key events in chronic myeloid leukemia transformation. Merkerova M; Bruchova H; Brdicka R Neoplasma; 2007; 54(6):503-10. PubMed ID: 17949234 [TBL] [Abstract][Full Text] [Related]
16. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG; Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158 [TBL] [Abstract][Full Text] [Related]
17. JAS-R, a new megakaryo-erythroid leukemic cell line that secretes erythropoietin. Sekikawa T; Iwase S; Saito S; Arakawa Y; Agawa M; Horiguchi-Yamada J; Yamada H Anticancer Res; 2006; 26(2A):843-50. PubMed ID: 16619478 [TBL] [Abstract][Full Text] [Related]
19. KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells. Nakamura S; Okinaka K; Hirano I; Ono T; Sugimoto Y; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K Leuk Res; 2008 Sep; 32(9):1358-65. PubMed ID: 18384876 [TBL] [Abstract][Full Text] [Related]
20. [Construction of a gastric cancer related gene GCRG213-specific siRNA expression vector and its effect on gastric cancer cells in vitro]. Gao LL; Wu BY; Wang MW; Zhan DW; Zhang L; You WD; Wang WH Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):84-8. PubMed ID: 17645837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]